Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

J Invest Dermatol. 2005 Nov;125(5):1020-5. doi: 10.1111/j.0022-202X.2005.23858.x.

Abstract

The use of calcineurin inhibitors in solid organ transplantation results in an increased risk of skin cancer. We examined the effect of these drugs on DNA repair in normal human keratinocytes after ultraviolet B (UVB) irradiation. We found that both cyclosporine A (CsA) and ascomycin inhibited removal of cyclobutane pyrimidine dimers, and that they also inhibited UVB-induced apoptosis. We also observed that UVB induced nuclear localization of the transcription factor nuclear factor of activated T-cells (NFAT), and that this was blocked by CsA and ascomycin. These data suggest that the increased risk of skin cancer observed in organ-transplant patients may be as a result of not only systemic immune suppression but also the local inhibition of DNA repair and apoptosis in skin by calcineurin inhibitors. These findings may have implications for the use of topical calcineurin inhibitors in sun-exposed skin and eyes.

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Apoptosis / drug effects
  • Calcineurin Inhibitors*
  • Cell Nucleus / chemistry
  • Cell Nucleus / metabolism
  • Cyclosporine / pharmacology*
  • DNA / radiation effects
  • DNA Damage / drug effects
  • DNA Repair / drug effects*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Keratinocytes / cytology
  • Keratinocytes / drug effects*
  • Keratinocytes / radiation effects
  • NFATC Transcription Factors / analysis
  • NFATC Transcription Factors / metabolism
  • Pyrimidine Dimers / metabolism
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / genetics
  • Skin Neoplasms / metabolism
  • Tacrolimus / analogs & derivatives*
  • Tacrolimus / pharmacology
  • Ultraviolet Rays*

Substances

  • Calcineurin Inhibitors
  • Enzyme Inhibitors
  • NFATC Transcription Factors
  • Pyrimidine Dimers
  • Cyclosporine
  • DNA
  • immunomycin
  • Tacrolimus